Blood Pressure, Systolic and Diastolic, and Cardiovascular Risks: US Population Data

The National High Blood Pressure Education Program (NHBPEP) was launched 20 years ago based on data from population studies and clinical trials that showed high blood pressure (HBP) was a major unsolved—but soluble—mass public health problem. The present review summarizes recent data from US prospective population studies on blood pressure—systolic (SBP), diastolic (DBP)—and cardiovascular risk. The outcome variables include blood pressure-related risks, primarily incidence and mortality from coronary heart disease, stroke, other and all cardiovascular diseases (CVD); also cardiac abnormalites (roentgenographic, electrocardiographic, echocardiographic); also, all-cause mortality and life expectancy. Data accrued during the past 20 years confirm that SBP and DBP have continuous, graded, strong, independent, etiologically significant relationships to the outcome variables. These relationships are documented for young, middle-aged, and older men and for middle-aged and older women of varying socioeconomic backgrounds and ethnicity. Among persons aged 35 years or more, most have SBP/DBP above optimal ( (Arch Intern Med. 1993;153:598-615)

[1]  R. Paffenbarger,et al.  Physical activity as an index of heart attack risk in college alumni. , 1978, American journal of epidemiology.

[2]  R. Prineas,et al.  All-cause mortality in the Hypertension Detection and Follow-up Program: findings for the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality. , 1986, Progress in cardiovascular diseases.

[3]  D. Reed,et al.  The nineteen-year trends in CHD in the Honolulu Heart Program. , 1989, International journal of epidemiology.

[4]  D. Reed,et al.  Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? , 1990, JAMA.

[5]  J. Neaton,et al.  Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. , 1992, Archives of internal medicine.

[6]  W. Kannel,et al.  Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study. , 1987, Journal of chronic diseases.

[7]  R. Beaglehole,et al.  Prevalence and incidence data in the assessment of the risk of coronary heart disease. , 1975, American journal of epidemiology.

[8]  Hypertension: Cardiovascular Implications in a Cohort of Old Old , 1992, Journal of the American Geriatrics Society.

[9]  Furberg Cd,et al.  Systolic hypertension in the elderly: controlled or uncontrolled. , 1990 .

[10]  R. Neuwirth,et al.  Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. , 1992, JAMA.

[11]  L. Kuller,et al.  Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. , 1988, Circulation.

[12]  D. Reed,et al.  A COMPARISON OF THE 12-YEAR MORTALITY AND PREDICTIVE FACTORS OF CORONARY HEART DISEASE AMONG JAPANESE MEN IN JAPAN AND HAWAII , 1988 .

[13]  L. Kuller,et al.  Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. , 1984, American heart journal.

[14]  P. D. Oldham Blood Pressure Study, 1979 , 1982 .

[15]  R. Brand,et al.  Coronary heart disease in Western Collaborative Group Study. Final follow-up experience of 8 1/2 years. , 1975, JAMA.

[16]  D. Levy,et al.  Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Framingham Heart Study. , 1989, Annals of internal medicine.

[17]  A. Dyer,et al.  Asymptomatic hyperglycemia and coronary heart disease in middle-aged men in two employed populations in Chicago. , 1979, Journal of chronic diseases.

[18]  A. Dyer,et al.  Major and minor electrocardiographic abnormalities and risk of death from coronary heart disease, cardiovascular diseases and all causes in men and women. , 1988, Journal of the American College of Cardiology.

[19]  M. Weber Coronary heart disease and hypertension. , 1994, American journal of hypertension.

[20]  D R Ragland,et al.  Coronary heart disease mortality in the Western Collaborative Group Study. Follow-up experience of 22 years. , 1988, American journal of epidemiology.

[21]  P. Whelton,et al.  Hypertension as a Risk Factor for Renal Disease Review of Clinical and Epidemiological Evidence , 1989, Hypertension.

[22]  K. Anderson,et al.  Twelve-year incidence of coronary heart disease in middle-aged adults during the era of hypertensive therapy: the Framingham offspring study. , 1991, The American journal of medicine.

[23]  R. Prineas,et al.  Hypertension detection and follow-up program. Baseline electrocardiographic characteristics of the hypertensive participants. , 1983, Hypertension.

[24]  D. Commerce Statistical abstract of the United States , 1978 .

[25]  M. Blaufox,et al.  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. , 1989, Hypertension.

[26]  P. Stolley,et al.  Risk factors for fatal heart attack in young women. , 1981, American journal of epidemiology.

[27]  A. Weyman,et al.  Cross-sectional echocardiographic assessment of regional left ventricular performance and myocardial perfusion. , 1986, Progress in cardiovascular diseases.

[28]  S. Pell,et al.  ACUTE MYOCARDIAL INFARCTION IN A LARGE INDUSTRIAL POPULATION: REPORT OF A 6-YEAR STUDY OF 1,356 CASES. , 1963, JAMA.

[29]  D. Reed,et al.  Predictors of sudden cardiac death among Hawaiian-Japanese men. , 1989, American journal of epidemiology.

[30]  J. Stamler Blood pressure and high blood pressure. Aspects of risk. , 1991, Hypertension.

[31]  R S Paffenbarger,et al.  Characteristics of longshoremen related fatal coronary heart disease and stroke. , 1971, American journal of public health.

[32]  A. Dyer,et al.  Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts. , 1993, Cardiology.

[33]  E. Barrett-Connor,et al.  Peripheral arterial disease in large vessels is epidemiologically distinct from small vessel disease. An analysis of risk factors. , 1989, American journal of epidemiology.

[34]  L. Wilkins Five-year findings of the Hypertension Detection and Follow-up Program. Prevention and reversal of left ventricular hypertrophy with antihypertensive drug therapy. Hypertension Detection and Follow-up Program Cooperative Group. , 1985, Hypertension.

[35]  J. Neaton,et al.  Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.

[36]  R. Shekelle,et al.  Hypertension and Risk of Stroke in an Elderly Population , 1974, Stroke.

[37]  D. Levy,et al.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.

[38]  James D. Neaton,et al.  Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men , 1992 .

[39]  A. Dyer,et al.  Hypertension in the elderly. , 1977, The Medical clinics of North America.

[40]  G. Friedman,et al.  Systolic Hypertension in the Elderly: An Epidemiologic Assessment , 1970, Circulation.

[41]  J. Neaton,et al.  Blood Pressure (Systolic and Diastolic) and Risk of Fatal Coronary Heart Disease , 1989, Hypertension.

[42]  T. Dawber,et al.  Primary prevention of the atherosclerotic diseases , 1970 .

[43]  J. Cutler,et al.  Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention Trial. , 1989, The American journal of cardiology.

[44]  D. Reed,et al.  Predictors of atherosclerosis in the Honolulu Heart Program. I. Biologic, dietary, and lifestyle characteristics. , 1987, American journal of epidemiology.

[45]  J. Feldman,et al.  Health status and well-being of the elderly : National Health and Nutrition Examination Survey--I Epidemiologic Follow-up study , 1990 .

[46]  Donald R. Miller,et al.  Myocardial infarction in women under 50 years of age. , 1983, JAMA.

[47]  N. Borhani,et al.  REPORT OF A TEN-YEAR FOLLOW-UP STUDY OF THE SAN FRANCISCO LONGSHOREMEN: MORTALITY FROM CORONARY HEART DISEASE AND FROM ALL CAUSES. , 1963, Journal of chronic diseases.

[48]  E. Barrett-Connor,et al.  Family history of heart attack: a modifiable risk factor? , 1986, Circulation.

[49]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[50]  J. Stamler Lectures on Preventive Cardiology , 1967 .

[51]  A. Dyer,et al.  Relationship of glucose tolerance to prevalence of ECG abnormalities and to 5-year mortality from cardiovascular disease: findings of the Chicago Heart Association Detection Project in Industry. , 1979, Journal of chronic diseases.

[52]  A. LaCroix,et al.  Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. , 1989, Archives of internal medicine.

[53]  E. Barrett-Connor,et al.  Isolated systolic hypertension and mortality after age 60 years. A prospective population-based study. , 1983, American journal of epidemiology.